17.03.2011 • NewsJames O'BrienAshlandPeople

James O'Brien to Have Colon Surgery

Ashland head James OBrien is expected to be out for two to three months...
Ashland head James O'Brien is expected to be out for two to three months following colon surgery.

Specialty chemicals company Ashland on Wednesday said Chairman and Chief Executive James O'Brien will have surgery to fix a perforated colon and be out for two to three months.

The company said he would be available on "a limited basis" until his full return.

Lead director Barry Perry will be interim chairman, while CFO Lamar Chambers and general counsel David Hausrath will assume his executive duties, Ashland said.

Separately, the company said it would repurchase $400 million in shares and that it intends to raise its annual dividend to 70 cents per share from 60 cents per share, beginning with the June 15 dividend payment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.